Healthcare Sector Review: Winning and Losing Stocks on Oct 12th

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • Gentiva Health Services (NASDAQ:GTIV): The shares closed at $4.50, up $0.66, or 17.19%, on the day. Its market capitalization is $137.74 million. About the company: Gentiva Health Services, Inc. provides specialty pharmaceutical and home health care services. The company provides products and services for hemophilia and bleeding disorders, growth hormone deficiency, RSV prevention and nutritional support services. Gentiva also provides services for diabetes, cardiovascular conditions, post-surgical care, orthopedic rehabilitation and other diseases.
  • Metabolix, Inc. (NASDAQ:MBLX): The shares closed at $4.88, up $0.51, or 11.67%, on the day. Its market capitalization is $166.32 million. About the company: Metabolix, Inc. produces biobased, biodegradable, natural plastics and chemicals.
  • STAAR Surgical Company (NASDAQ:STAA): The shares closed at $8.84, up $0.92, or 11.62%, on the day. Its market capitalization is $315.32 million. About the company: STAAR Surgical Company develops, manufactures, and markets high margin visual implants that improve a patient’s quality of vision. The Company manufactures implantable contact lenses to treat refractive disorders such as myopia. STAAR also manufactures products for cataract surgery and glaucoma surgery.
  • Columbia Laboratories Inc (NASDAQ:CBRX): The shares closed at $2.41, up $0.25, or 11.57%, on the day. Its market capitalization is $210.32 million. About the company: Columbia Laboratories, Inc. is an international pharmaceutical company that develops and markets women’s health care and endocrinology products. The Company develops products intended to treat infertility, dysmenorrhea, endometriosis, and hormonal deficiencies, primarily utilizing its Bioadhesive Delivery System technology. Columbia markets Striant, and Prochieve 8% and 4%.
  • Micromet Inc. (NASDAQ:MITI): The shares closed at $5.69, up $0.46, or 8.8%, on the day. Its market capitalization is $523.74 million. About the company: Micromet, Inc. is a biotechnology company. The Company develops novel antibody-based drugs for the treatment of cancer, inflammation and autoimmune diseases.

Losers (% price change)

  • Pharmasset, Inc. (NASDAQ:VRUS): The shares closed at $78.23, down $5.29, or 6.33%, on the day. Its market capitalization is $5.90 billion. About the company: Pharmasset, Inc. is a pharmaceutical company. The Company develops oral therapeutics for the human immunodeficiency virus (HIV), hepatitis B (HBV), and hepatitis C (HCV).
  • InterMune, Inc. (NASDAQ:ITMN): The shares closed at $21.74, down $1.45, or 6.25%, on the day. Its market capitalization is $1.32 billion. About the company: InterMune, Inc. is a biopharmaceutical company. The Company develops therapies for hepatology and pulmonology, including treatments for severe, malignant osteopetrosis and chronic granulomatous disease
  • Volcano Corporation (NASDAQ:VOLC): The shares closed at $25.32, down $1.59, or 5.91%, on the day. Its market capitalization is $1.33 billion. About the company: Volcano Corporation develops, manufactures, and commercializes medical devices. The Company’s products include intravascular ultrasound (IVUS) catheters and Functional Measurement guide wires used to diagnose and assess diseases of the coronary and peripheral vasculature.
  • Synergetics USA Inc. (NASDAQ:SURG): The shares closed at $5.90, down $0.37, or 5.9%, on the day. Its market capitalization is $147.30 million. About the company: Synergetics USA, Inc. develops and manufactures medical devices and products for the hospital and healthcare communities. The Company’s products include bipolar electrosurgical generators and disposable and non-disposable medical products.
  • Alexion Pharmaceuticals (NASDAQ:ALXN): The shares closed at $65.97, down $2.86, or 4.16%, on the day. Its market capitalization is $12.17 billion. About the company: Alexion Pharmaceuticals, Inc., a biopharmaceutical company, researches and develops proprietary immunoregulatory compounds for the treatment of autoimmune and cardiovascular diseases. The Company develops C5 complement inhibitors and Apogens which are two classes of potential therapeutic compounds designed to selectively target specific disease-causing segments of the immune system.

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>